Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Cell-Based Treatments for Avascular Necrosis

Cell-Based Treatments for Avascular Necrosis

Mirzayev, A. B.
Asilova, S. U.
Babakulov, A. Sh

Paperback

Medical Reference

ISBN10: 6208438691
ISBN13: 9786208438692
Publisher: LAP Lambert Academic Publishing
Published: Mar 27 2025
Pages: 64
Weight: 0.22
Height: 0.15 Width: 6.00 Depth: 9.00
Language: English
Avascular necrosis (AVN), also referred to as osteonecrosis, is a degenerative bone disorder resulting from impaired blood flow to bone tissue, ultimately causing structural collapse, chronic pain, and functional loss. In the wake of the COVID-19 pandemic, AVN has emerged as a particularly concerning sequela, especially among younger patients exposed to high-dose corticosteroid therapy or post-viral vascular complications. The conventional endpoint for many AVN patients-total hip replacement-is often inappropriate or undesired in young adults. Hence, this monograph explores a critical area of regenerative orthopedic medicine: cell-based, joint-preserving therapies for AVN.The text centers around minimally invasive biologic interventions, such as core decompression (CD) in combination with cell-based therapies like bone marrow aspirate concentrate (BMAC), stromal vascular fraction (SVF) from adipose tissue, and platelet-rich plasma (PRP). These strategies aim to harness the regenerative potential of mesenchymal stem cells (MSCs) and biologically active growth factors to promote vascularization, stimulate osteogenesis, and delay or prevent the need for joint arthroplasty.

Also in

Medical Reference

View All